Characterization of LY2228820 Dimesylate, a Potent and...

Molecular Cancer Therapeutics 2014 / 02 Vol. 13; Iss. 2

Characterization of LY2228820 Dimesylate, a Potent and Selective Inhibitor of p38 MAPK with Antitumor Activity

Campbell, R. M., Anderson, B. D., Brooks, N. A., Brooks, H. B., Chan, E. M., De Dios, A., Gilmour, R., Graff, J. R., Jambrina, E., Mader, M., McCann, D., Na, S., Parsons, S. H., Pratt, S. E., Shih, C.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
13
Language:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.mct-13-0513
Date:
February, 2014
File:
PDF, 833 KB
english, 2014
Conversion to is in progress
Conversion to is failed